Hybrid

 Hybrid (self-paced with live-virtual Q&A) • Sep 22–Nov 28, 2025 

An intermediate-level course building on Cell Product Handling & Regulatory 101 and Essentials of Cell Therapy Product Manufacturing, Qualification, and Validation, providing key knowledge and best practices in cell therapy biomanufacturing, characterization, and regulatory frameworks.

Target Audience: Undergraduate students with a Science degree interested in entering the CGT field, as well as professionals seeking to expand their knowledge of CGT bioprocessing and best practices.

LEARN MORE →

 Hybrid (self-paced with live-virtual Q&A)

An intermediate-level course focuses on methods for reprogramming somatic cells into induced pluripotent stem cells (iPSCs), colony identification, and quality assays for cell therapy applications.

Target Audience: Researchers, lab professionals, and process development engineers with cell culture experience, seeking to master best practices for culturing iPSCs and their application in cell therapies.

LEARN MORE →

 Hybrid (self-paced with hands-on lab training)

An advanced education program for professionals residing in Europe to gain knowledge and hands-on practical experience for developing ATMPs for human use.

Target Audience: Professionals residing in Europe working or intending to work in GMP-compliant facilities producing cell therapy, gene therapy, or tissue-engineered products for human use.

LEARN MORE →